Galmed Pharmaceuticals (GLMD) Operating Leases (2019 - 2025)
Galmed Pharmaceuticals (GLMD) posted quarterly Operating Leases of $80000.0 for Q4 2025, up 207.69% year-over-year from $26000.0 in Q4 2024, and up 207.69% quarter-over-quarter from $26000.0 in Q4 2024.
Galmed Pharmaceuticals (GLMD) Operating Leases (2019 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Operating Leases history runs 6 years deep, the most recent figure standing at $80000.0 for Q4 2025.
- In Q4 2025, Operating Leases rose 207.69% year-over-year to $80000.0; the TTM figure through Dec 2025 stood at $80000.0 (up 207.69% YoY), while the FY2025 annual figure was $80000.0, up 207.69% from the prior year.
- Operating Leases for Q4 2025 stood at $80000.0, up from $26000.0 in the prior quarter.
- The five-year high for Operating Leases was $435000.0 in Q4 2021, with the low at $26000.0 in Q4 2024.
- The 4-year median for Operating Leases is $158500.0 (2022), against an average of $186600.0.
- The sharpest annual moves came in 2021 and 2025: Operating Leases plunged 99.8% in 2021, then soared 207.69% in 2025.
- Galmed Pharmaceuticals' Operating Leases stood at $435000.0 in 2021, then plunged by 89.89% to $44000.0 in 2022, then plunged by 40.91% to $26000.0 in 2024, then jumped by 207.69% to $80000.0 in 2025.
- Business Quant data shows GLMD's Operating Leases at $80000.0 in Q4 2025, $26000.0 in Q4 2024, and $44000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.28 Mn | -9.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | 134,000.00 |
| Mar 31, 2022 | 183,000.00 |
| Dec 31, 2021 | 435,000.00 |
| Sep 30, 2021 | 274,000.00 |
| Jun 30, 2021 | 318,000.00 |
| Mar 31, 2021 | 283,000.00 |
| Dec 31, 2020 | 216.00 Mn |
| Sep 30, 2020 | 247,000.00 |
| Jun 30, 2020 | 251,000.00 |
| Mar 31, 2020 | 302,000.00 |
| Dec 31, 2019 | 352,000.00 |
| Sep 30, 2019 | 389,000.00 |
| Jun 30, 2019 | 442,000.00 |
| Mar 31, 2019 | 499,000.00 |